Neurodegeneration by Activation of the Microglial Complement–Phagosome Pathway

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Neuroscience

• Publication date

  2014-06-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1523/JNEUROSCI.5002-13.2014PMID 24948809PMCID PMC6608212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microglial phagocytosis of live neurons

  2014cited by this paper
• Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.

  2013cited by this paper
• Phagocytosis executes delayed neuronal death after focal brain ischemia

  2013cited by this paper
• NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration

  2013cited by this paper
• Microglia and neurodegeneration: The role of systemic inflammation

  2013cited by this paper
• Neuroinflammation in Parkinson's disease.

  2012cited by this paper
• C3-dependent mechanism of microglial priming relevant to multiple sclerosis

  2012cited by this paper
• Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis

  2012cited by this paper
• Microglial carbohydrate-binding receptors for neural repair

  2012cited by this paper
• Eaten alive! Cell death by primary phagocytosis: 'phagoptosis'.

  2012cited by this paper
• NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson's Disease

  2012cited by this paper
• Sialic Acid on the Neuronal Glycocalyx Prevents Complement C1 Binding and Complement Receptor-3-Mediated Removal by Microglia

  2012cited by this paper
• Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.

  2012cited by this paper
• Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

  2012cited by this paper
• Redox sensitivity of tyrosine hydroxylase activity and expression in dopaminergic dysfunction.

  2012cited by this paper
• Lipopolysaccharide-Induced Microglial Activation and Neuroprotection against Experimental Brain Injury Is Independent of Hematogenous TLR4

  2012cited by this paper
• Involvement of the Fcγ Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss*

  2011cited by this paper
• Systemic Inflammation Modulates Fc Receptor Expression on Microglia during Chronic Neurodegeneration

  2011cited by this paper
• Mechanisms underlying inflammation in neurodegeneration.

  2010cited by this paper
• Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease

  2010cited by this paper
• Contribution of systemic inflammation to chronic neurodegeneration

  2010cited by this paper
• Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease

  2009cited by this paper
• Cross-regulation of signaling by ITAM-associated receptors

  2009cited by this paper
• Microglial physiology: unique stimuli, specialized responses.

  2009cited by this paper
• A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse.

  2009cited by this paper
• Neuroinflammation in Parkinson’s Disease

  2009cited by this paper
• The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery

  2008cited by this paper
• Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration

  2008cited by this paper
• Debris clearance by microglia: an essential link between degeneration and regeneration

  2008cited by this paper
• Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex

  2008cited by this paper
• Developmental Neuronal Death in Hippocampus Requires the Microglial CD11b Integrin and DAP12 Immunoreceptor

  2008cited by this paper
• From inflammation to sickness and depression: when the immune system subjugates the brain

  2008cited by this paper
• The classical complement cascade mediates CNS synapse elimination.

  2007cited by this paper
• Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

  2007cited by this paper
• Systemic infections and inflammation affect chronic neurodegeneration

  2007influential reference
• MAC1 mediates LPS‐induced production of superoxide by microglia: The role of pattern recognition receptors in dopaminergic neurotoxicity

  2007cited by this paper
• Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

  2007cited by this paper
• Control of microglial neurotoxicity by the fractalkine receptor

  2006cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease.

  2004cited by this paper
• The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.

  2003cited by this paper
• Molecular insights on the cerebral innate immune system.

  2003cited by this paper
• Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.

  2002cited by this paper
• Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

  2002cited by this paper
• Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

  2000cited by this paper
• Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

  1999cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995influential reference
• Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain.

  1990cited by this paper

• Acute "in vivo" LPS causes an early presynaptic C1q and C3 accumulation and increases the "prunability" of cortical synaptosomes.

  2026cites this paper
• Microglia at the Forefront: New Insights From the Glial Club South Cone Meeting 2025

  2026cites this paper
• Tailoring treatments: pharmacogenomics in the management of neurodegenerative diseases.

  2026cites this paper
• Vascular smooth muscle cell loss, but not neuroinflammation, drives cerebrovascular reactivity impairment in Alzheimer's disease

  2026cites this paper
• Complement, Inflammasome, and Microglial Crosstalk in Glaucoma: From Neurodegeneration to Immune-Based Precision Therapy

  2026cites this paper
• Spatial transcriptomic alterations of the dorsal horn in dogs with neuropathic pain

  2025cites this paper
• Microglia endotoxin tolerance is retained after enforced repopulation.

  2025cites this paper
• Metabolic regulation of immune memory and function of microglia

  2025influential citation
• Glutamatergic argonaute2 promotes the formation of the neurovascular unit in mice.

  2025cites this paper
• Vascular smooth muscle cell loss, but not neuroinflammation, drives cerebrovascular reactivity impairment in Alzheimer’s disease

  2025cites this paper
• Knowing the enemy: strategic targeting of complement to treat Alzheimer disease

  2025cites this paper
• Selected Interleukins Relevant to Multiple Sclerosis: New Directions, Potential Targets and Therapeutic Perspectives

  2024cites this paper
• The microglial P2Y6 receptor as a therapeutic target for neurodegenerative diseases

  2024cites this paper
• The endotoxin hypothesis of Alzheimer’s disease

  2024cites this paper
• Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson’s disease

  2024cites this paper
• Effects of different types of induced neonatal inflammation on development and behavior of C57BL/6 and BTBR mice.

  2024cites this paper
• Neuroinflammation generated by HIV-infected microglia promotes dysfunction and death of neurons in human brain organoids

  2024cites this paper
• Microglia heterogeneity during neuroinflammation and neurodegeneration in the mouse retina

  2024influential citation
• Short chain fatty acids mediates complement C1q pathway alleviation of perioperative neurocognitive disorders.

  2024cites this paper
• Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synuclein

  2024cites this paper
• Lipopolysaccharide Effects on Neurotransmission: Understanding Implications for Depression

  2024cites this paper
• Neuroprotective role of sialic-acid-binding immunoglobulin-like lectin-11 in humanized transgenic mice

  2024cites this paper
• Gut dysbiosis induces the development of depression-like behavior through abnormal synapse pruning in microglia-mediated by complement C3

  2024cites this paper
• Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance

  2024cites this paper
• Associations of Microbiota and Nutrition with Cognitive Impairment in Diseases

  2024cites this paper
• LINE-1 retrotransposons contribute to mouse PV interneuron development

  2024cites this paper
• Crosstalk between peripheral inflammation and brain: focus on the responses of microglia and astrocytes to peripheral challenge.

  2024cites this paper
• The deficient CLEC5A ameliorates the behavioral and pathological deficits via the microglial Aβ clearance in Alzheimer’s disease mouse model

  2024cites this paper
• PARK7/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammation

  2024cites this paper
• Metabolic Endotoxemia: From the Gut to Neurodegeneration

  2024cites this paper
• Circadian regulation of microglia function: Potential targets for treatment of Parkinson's Disease.

  2024cites this paper
• Neuroimmunomodulatory properties of polysialic acid

  2023cites this paper
• Structure, Function, and Molecular Landscapes of the Aging Retina.

  2023cites this paper
• The Endotoxin Hypothesis of Parkinson's Disease

  2023influential citation
• Alteration in mitochondrial dynamics promotes the proinflammatory response of microglia and is involved in cerebellar dysfunction of young and aged mice following LPS exposure.

  2023cites this paper
• Characterization of Lipopolysaccharide Effects on LRRK2 Signaling in RAW Macrophages

  2023cites this paper
• Botulinum neurotoxin A ameliorates depressive-like behavior in a reserpine-induced Parkinson’s disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation

  2023cites this paper
• Hippocampal Upregulation of Complement Component C3 in Response to Lipopolysaccharide Stimuli in a Model of Fragile-X Syndrome

  2023cites this paper
• Intestinal permeability and its significance in psychiatric disorders - a narrative review and future perspectives.

  2023cites this paper
• Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors

  2023cites this paper
• LINE-1 retrotransposon activation intrinsic to interneuron development

  2023cites this paper
• Primary cilia-mediated regulation of microglial secretion in Alzheimer’s disease

  2023cites this paper
• Lamin A/C mediates microglial activation by modulating cell proliferation and immune response

  2023cites this paper
• Complement Receptor C3aR1 Contributes to Paclitaxel-Induced Peripheral Neuropathic Pain in Mice and Rats.

  2023cites this paper
• LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.

  2023cites this paper
• Aging, Parkinson’s Disease, and Models: What Are the Challenges?

  2023cites this paper
• Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype

  2023cites this paper
• Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathy

  2023cites this paper
• TLR2 Mediates Microglial Activation and Contributes to Central Sensitization in a Recurrent Nitroglycerin-induced Chronic Migraine Model

  2023cites this paper
• Complement C3 Enhances LPS-Elicited Neuroinflammation and Neurodegeneration Via the Mac1/NOX2 Pathway

  2023cites this paper
• Early Neuroimaging Markers in β Propeller Protein-Associated Neurodegeneration

  2022cites this paper
• Neurodegenerative Diseases: Implications of Environmental and Climatic Influences on Neurotransmitters and Neuronal Hormones Activities

  2022cites this paper
• Cerebrospinal Fluid Biomarkers of Japanese Encephalitis [ version 2 ; peer review : 3 approved ]

  2022cites this paper
• Emerging roles of leptin in Parkinson's disease: chronic inflammation, neuroprotection and more?

  2022cites this paper
• Lipopolysaccharide mouse models for Parkinson’s disease research: a critical appraisal

  2022cites this paper
• Inflammatory Animal Models of Parkinson’s Disease

  2022cites this paper
• Macrophage depletion blocks congenital SARM1-dependent neuropathy

  2022cites this paper
• MiR-30a-5p and miR-153-3p regulate LPS-induced neuroinflammatory response and neuronal apoptosis by targeting NeuroD1

  2022cites this paper
• High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice

  2022cites this paper
• The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration

  2022cites this paper
• INFLAMMATORY BOWEL DISEASE INDUCES α-SYNUCLEIN AGGREGATION IN GUT AND BRAIN

  2022cites this paper
• Targeting Microglia to Treat Degenerative Eye Diseases

  2022cites this paper
• Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model

  2022cites this paper
• Protective effects of endotoxin tolerance on peripheral lipopolysaccharide-induced neuroinflammation and dopaminergic neuronal injury

  2022cites this paper
• iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson’s Disease

  2021cites this paper
• The development and physiological and pathophysiological functions of resident macrophages and glial cells.

  2021cites this paper
• Cholinergic Modulation of the Immune System in Neuroinflammatory Diseases

  2021cites this paper
• Potential roles of functional bacterial amyloid proteins, bacterial biosurfactants and other putative gut microbiota products in the etiopathogeny of Parkinson’s Disease

  2021cites this paper
• Cerebral dysfunctions caused by sepsis during ageing

  2021cites this paper
• Brain physiome: A concept bridging in vitro 3D brain models and in silico models for predicting drug toxicity in the brain

  2021cites this paper
• Novel Mechanisms to Modulate Microglial Functional Phenotypes in Health and Disease

  2021cites this paper
• Immunotherapies for Neurodegenerative Diseases

  2021cites this paper
• Microglia in Health and Disease: The Strength to Be Diverse and Reactive

  2021cites this paper
• Potential Genes and Mechanisms Linking Intracerebral Hemorrhage and Depression: A Bioinformatics-Based Study

  2021cites this paper
• The Efficacy of Systemic Administration of Lipopolysaccharide in Modelling Pre-motor Parkinson's Disease in C57BL/6 mice.

  2021cites this paper
• Microglia at the Centre of Brain Research: Accomplishments and Challenges for the Future

  2021cites this paper
• Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice

  2021cites this paper
• Microglial phagocytosis of neurons in neurodegeneration, and its regulation

  2021cites this paper
• The Role of Gut Microbiota and Gut–Brain Interplay in Selected Diseases of the Central Nervous System

  2021cites this paper
• Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing

  2021cites this paper
• Acute neuroinflammation increases excitability of prefrontal parvalbumin interneurons and their functional recruitment during novel object recognition.

  2021cites this paper
• Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson’s Disease in C57BL/6 Mice

  2021cites this paper
• Low molecular weight polysialic acid prevents lipopolysaccharide‐induced inflammatory dopaminergic neurodegeneration in humanized SIGLEC11 transgenic mice

  2021influential citation
• Circulating HMGB1 is elevated in veterans with Gulf War Illness and triggers the persistent pro-inflammatory microglia phenotype in male C57Bl/6J mice

  2021cites this paper
• Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders

  2021cites this paper
• Cochlear Immune Response in Presbyacusis: a Focus on Dysregulation of Macrophage Activity

  2021cites this paper
• Altered ribosomal function and protein synthesis caused by tau

  2021cites this paper
• Animal models of brain-first and body-first Parkinson's disease.

  2021cites this paper
• Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis.

  2021cites this paper
• The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives

  2021cites this paper
• Transcriptional signature in microglia isolated from an Alzheimer's disease mouse model treated with scanning ultrasound

  2021cites this paper
• Single-Cell Transcriptomics and In Situ Morphological Analyses Reveal Microglia Heterogeneity Across the Nigrostriatal Pathway

  2021cites this paper
• Phagocytosis‐related NADPH oxidase 2 subunit gp91phox contributes to neurodegeneration after repeated systemic challenge with lipopolysaccharides

  2020influential citation
• Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?

  2020cites this paper
• Complement: Bridging the innate and adaptive immune systems in sterile inflammation

  2020cites this paper
• Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with mucopolysaccharidosis type VII

  2020cites this paper
• West Nile Virus-Induced Neurologic Sequelae—Relationship to Neurodegenerative Cascades and Dementias

  2020cites this paper
• The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia

  2020influential citation
• Transcriptome analysis reveals dysregulation of genes involved in oxidative phosphorylation in a murine model of retinopathy of prematurity

  2020cites this paper
• Chronic intermittent ethanol and lipopolysaccharide exposure differentially alter Iba1‐derived microglia morphology in the prelimbic cortex and nucleus accumbens core of male Long‐Evans rats

  2020cites this paper